台基股份 reported revenue of ¥0.22B for the period ended 2026-06-30, +22.2% year on year. Net income was ¥0.03B, a 15.2% net margin on a 25.7% gross margin. The largest revenue line is 晶闸管 at 53% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | +22.2% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | -15.1% |
| Gross margin | 25.7% | Net margin 15.2% |
| Revenue Q/Q | +39.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 晶闸管 | ¥0.12B | 52.9% |
| 模块 | ¥0.09B | 41.9% |
| 其他 | ¥0.01B | 5.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.16B | 74.3% |
| R&D | ¥0.01B | 3.7% |
| SG&A | ¥0.02B | 8.9% |
| Tax & other | ¥0.01B | 2.3% |
| Item | Amount |
|---|---|
| Total assets | ¥1.29B |
| Total liabilities | ¥0.14B |
| Shareholders' equity | ¥1.15B |
| Equity / assets | 89.3% |
| Operating cash flow | ¥0.02B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 48% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
天源迪科 ・ 合康新能 ・ 福瑞医科 ・ 世纪鼎利 ・ 琏升科技 ・ 中青宝 ・ 航宇微 ・ 鼎龙股份 ・ 万邦达 ・ 中创环保 ・ 万顺新材 ・ 蓝色光标
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies